Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Brian Cheng's Stock Ratings
JP Morgan Analyst
Brian Cheng is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/19/2025
Overall Average Return
-17.9%
Smart Score
Overall Average Return Percentile
13th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 06/02/2025 | BPMC | Buy Now | Blueprint Medicines | $128.12 | 0.69% | Brian Cheng39% | $130 → $129 | Downgrade | Overweight → Neutral | Get Alert |
| 05/13/2025 | ITOS | Buy Now | ITeos Therapeutics | $10.00 | -20% | Brian Cheng39% | $15 → $8 | Downgrade | Overweight → Neutral | Get Alert |
| 05/02/2025 | CGON | Buy Now | CG Oncology | $26.28 | 56.01% | Brian Cheng39% | → $41 | Initiates | → Overweight | Get Alert |
| 03/27/2025 | AAPG | Buy Now | Ascentage Pharma Group | $34.96 | — | Brian Cheng39% | — | Initiates | → Overweight | Get Alert |
| 03/06/2025 | ITOS | Buy Now | ITeos Therapeutics | $10.00 | 50% | Brian Cheng39% | $22 → $15 | Maintains | Overweight | Get Alert |
| 03/04/2025 | PTGX | Buy Now | Protagonist Therapeutics | $53.92 | 5.71% | Brian Cheng39% | $53 → $57 | Maintains | Overweight | Get Alert |
| 02/28/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.30 | 39.78% | Brian Cheng39% | $45 → $13 | Downgrade | Overweight → Neutral | Get Alert |
| 02/04/2025 | PTGX | Buy Now | Protagonist Therapeutics | $53.92 | -1.71% | Brian Cheng39% | $51 → $53 | Maintains | Overweight | Get Alert |
| 02/04/2025 | BPMC | Buy Now | Blueprint Medicines | $128.12 | 0.69% | Brian Cheng39% | $126 → $129 | Maintains | Overweight | Get Alert |
| 01/30/2025 | CRGX | Buy Now | Cargo Therapeutics | $4.35 | — | Brian Cheng39% | — | Downgrade | Overweight → Underweight | Get Alert |
| 12/16/2024 | EDIT | Buy Now | Editas Medicine | $2.35 | — | Brian Cheng39% | — | Downgrade | Neutral → Underweight | Get Alert |
| 12/16/2024 | ZYME | Buy Now | Zymeworks | $12.63 | 42.52% | Brian Cheng39% | → $18 | Upgrade | Neutral → Overweight | Get Alert |
| 11/14/2024 | BPMC | Buy Now | Blueprint Medicines | $128.12 | -1.65% | Brian Cheng39% | → $126 | Initiates | → Overweight | Get Alert |
| 11/07/2024 | XNCR | Buy Now | Xencor | $8.36 | 234.93% | Brian Cheng39% | $27 → $28 | Maintains | Overweight | Get Alert |
| 08/12/2024 | ITOS | Buy Now | ITeos Therapeutics | $10.00 | 140% | Brian Cheng39% | $27 → $24 | Maintains | Overweight | Get Alert |
| 08/12/2024 | NTLA | Buy Now | Intellia Therapeutics | $9.30 | 491.4% | Brian Cheng39% | $61 → $55 | Maintains | Overweight | Get Alert |
| 08/08/2024 | IMVT | Buy Now | Immunovant | $15.86 | 190.04% | Brian Cheng39% | $51 → $46 | Maintains | Overweight | Get Alert |
| 07/31/2024 | XNCR | Buy Now | Xencor | $8.36 | 222.97% | Brian Cheng39% | $30 → $27 | Maintains | Overweight | Get Alert |
| 07/31/2024 | KYTX | Buy Now | Kyverna Therapeutics | $3.17 | 941.01% | Brian Cheng39% | $39 → $33 | Maintains | Overweight | Get Alert |
| 07/25/2024 | PTGX | Buy Now | Protagonist Therapeutics | $53.92 | -10.98% | Brian Cheng39% | $39 → $48 | Maintains | Overweight | Get Alert |
| 05/02/2024 | MGX | Buy Now | Metagenomi | $1.55 | 287.1% | Brian Cheng39% | $16 → $6 | Downgrade | Overweight → Neutral | Get Alert |
| 04/30/2024 | IMNM | Buy Now | Immunome | $8.83 | 171.8% | Brian Cheng39% | → $24 | Initiates | → Overweight | Get Alert |
| 03/22/2024 | PGEN | Buy Now | Precigen | $1.50 | — | Brian Cheng39% | — | Downgrade | Neutral → Underweight | Get Alert |
| 03/19/2024 | MRSN | Buy Now | Mersana Therapeutics | $0.36 | 1304.89% | Brian Cheng39% | → $5 | Upgrade | Underweight → Neutral | Get Alert |
| 03/12/2024 | ITOS | Buy Now | ITeos Therapeutics | $10.00 | 170% | Brian Cheng39% | $29 → $27 | Maintains | Overweight | Get Alert |
| 03/05/2024 | MGX | Buy Now | Metagenomi | $1.55 | 932.26% | Brian Cheng39% | → $16 | Initiates | → Overweight | Get Alert |
| 03/04/2024 | KYTX | Buy Now | Kyverna Therapeutics | $3.17 | 1130.28% | Brian Cheng39% | → $39 | Initiates | → Overweight | Get Alert |
| 02/28/2024 | PTGX | Buy Now | Protagonist Therapeutics | $53.92 | -31.38% | Brian Cheng39% | $34 → $37 | Maintains | Overweight | Get Alert |
| 02/27/2024 | ALLO | Buy Now | Allogene Therapeutics | $1.31 | 510.69% | Brian Cheng39% | $9 → $8 | Maintains | Overweight | Get Alert |
| 02/27/2024 | EDIT | Buy Now | Editas Medicine | $2.35 | 282.98% | Brian Cheng39% | $8 → $9 | Maintains | Neutral | Get Alert |
| 02/20/2024 | IMVT | Buy Now | Immunovant | $15.86 | 221.56% | Brian Cheng39% | → $51 | Initiates | → Overweight | Get Alert |
| 12/05/2023 | CRGX | Buy Now | Cargo Therapeutics | $4.35 | 428.74% | Brian Cheng39% | → $23 | Initiates | → Overweight | Get Alert |
| 11/14/2023 | ROIV | Buy Now | Roivant Sciences | $11.35 | 32.16% | Brian Cheng39% | $16 → $15 | Maintains | Overweight | Get Alert |
| 10/18/2023 | EDIT | Buy Now | Editas Medicine | $2.35 | 240.43% | Brian Cheng39% | → $8 | Upgrade | Underweight → Neutral | Get Alert |
| 09/25/2023 | PTGX | Buy Now | Protagonist Therapeutics | $53.92 | -36.94% | Brian Cheng39% | $36 → $34 | Maintains | Overweight | Get Alert |
| 09/25/2023 | BCAB | Buy Now | BioAtla | $0.42 | 3246.08% | Brian Cheng39% | $17 → $14 | Maintains | Overweight | Get Alert |
| 09/25/2023 | ALLO | Buy Now | Allogene Therapeutics | $1.31 | 587.02% | Brian Cheng39% | $11 → $9 | Maintains | Overweight | Get Alert |
| 08/10/2023 | ADCT | Buy Now | ADC Therapeutics | $3.07 | — | Brian Cheng39% | — | Upgrade | Underweight → Neutral | Get Alert |
| 08/02/2023 | BCAB | Buy Now | BioAtla | $0.42 | 3963.1% | Brian Cheng39% | $19 → $17 | Maintains | Overweight | Get Alert |
| 06/16/2023 | MRSN | Buy Now | Mersana Therapeutics | $0.36 | 1304.89% | Brian Cheng39% | $11 → $5 | Downgrade | Overweight → Neutral | Get Alert |
| 06/01/2023 | ACET | Buy Now | Adicet Bio | $0.67 | 801.85% | Brian Cheng39% | $20 → $6 | Downgrade | Overweight → Neutral | Get Alert |
| 05/23/2023 | PGEN | Buy Now | Precigen | $1.50 | — | Brian Cheng39% | — | Initiates | → Neutral | Get Alert |
| 05/18/2023 | ROIV | Buy Now | Roivant Sciences | $11.35 | 23.35% | Brian Cheng39% | $12 → $14 | Maintains | Overweight | Get Alert |
| 04/03/2023 | BCAB | Buy Now | BioAtla | $0.42 | 4441.11% | Brian Cheng39% | $23 → $19 | Maintains | Overweight | Get Alert |
| 03/31/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.30 | 749.46% | Brian Cheng39% | $82 → $79 | Maintains | Overweight | Get Alert |
| 03/31/2023 | ZYME | Buy Now | Zymeworks | $12.63 | -28.74% | Brian Cheng39% | $8 → $9 | Maintains | Neutral | Get Alert |
| 03/29/2023 | ROIV | Buy Now | Roivant Sciences | $11.35 | 5.73% | Brian Cheng39% | → $12 | Maintains | Overweight | Get Alert |
| 03/16/2023 | MRSN | Buy Now | Mersana Therapeutics | $0.36 | 2709.78% | Brian Cheng39% | → $10 | Upgrade | Neutral → Overweight | Get Alert |
| 02/13/2023 | XNCR | Buy Now | Xencor | $8.36 | 402.39% | Brian Cheng39% | $37 → $42 | Maintains | Overweight | Get Alert |
| 02/13/2023 | ROIV | Buy Now | Roivant Sciences | $11.35 | -3.08% | Brian Cheng39% | $10 → $11 | Maintains | Overweight | Get Alert |
| 01/24/2023 | ALLO | Buy Now | Allogene Therapeutics | $1.31 | 739.69% | Brian Cheng39% | $20 → $11 | Upgrade | Neutral → Overweight | Get Alert |
| 01/10/2023 | ROIV | Buy Now | Roivant Sciences | $11.35 | -11.89% | Brian Cheng39% | $9 → $10 | Maintains | Overweight | Get Alert |
| 12/16/2022 | SNTI | Buy Now | Senti Biosciences | $2.25 | — | Brian Cheng39% | — | Initiates | → Neutral | Get Alert |
| 12/12/2022 | ROIV | Buy Now | Roivant Sciences | $11.35 | -20.7% | Brian Cheng39% | → $9 | Maintains | Overweight | Get Alert |
| 12/07/2022 | GOSS | Buy Now | Gossamer Bio | $1.29 | — | Brian Cheng39% | — | Downgrade | Neutral → Underweight | Get Alert |
| 11/10/2022 | CLVS | Buy Now | Clovis Oncology | — | — | Brian Cheng39% | — | Downgrade | Neutral → Underweight | Get Alert |
| 09/21/2022 | NTLA | Buy Now | Intellia Therapeutics | $9.30 | 813.98% | Brian Cheng39% | → $85 | Initiates | → Overweight | Get Alert |
| 09/21/2022 | ACET | Buy Now | Adicet Bio | $0.67 | 3357.09% | Brian Cheng39% | → $23 | Initiates | → Overweight | Get Alert |
| 09/21/2022 | XNCR | Buy Now | Xencor | $8.36 | 342.58% | Brian Cheng39% | → $37 | Initiates | → Overweight | Get Alert |
| 09/21/2022 | ADCT | Buy Now | ADC Therapeutics | $3.07 | 63.02% | Brian Cheng39% | → $5 | Initiates | → Overweight | Get Alert |
| 09/21/2022 | GOSS | Buy Now | Gossamer Bio | $1.29 | 1217.83% | Brian Cheng39% | → $17 | Initiates | → Neutral | Get Alert |
| 01/07/2022 | PSTX | Buy Now | Poseida Therapeutics | — | — | Brian Cheng39% | → $24 | Initiates | → Overweight | Get Alert |
| 11/30/2021 | SRRA | Buy Now | Sierra Oncology | — | — | Brian Cheng39% | $33 → $39 | Maintains | Overweight | Get Alert |
| 10/29/2021 | IMNM | Buy Now | Immunome | $8.83 | 296.38% | Brian Cheng39% | → $35 | Initiates | → Overweight | Get Alert |
| 09/27/2021 | SRRA | Buy Now | Sierra Oncology | — | — | Brian Cheng39% | → $33 | Initiates | → Overweight | Get Alert |
| 09/02/2021 | RGLS | Buy Now | Regulus Therapeutics | $8.20 | -75.61% | Brian Cheng39% | → $2 | Initiates | → Overweight | Get Alert |
| 08/10/2021 | ARCT | Buy Now | Arcturus Therapeutics | $12.35 | 588.26% | Brian Cheng39% | $71 → $85 | Maintains | Overweight | Get Alert |
| 08/03/2021 | BCRX | Buy Now | BioCryst Pharma | $9.97 | 110.63% | Brian Cheng39% | → $21 | Initiates | → Overweight | Get Alert |
| 07/02/2021 | ARCT | Buy Now | Arcturus Therapeutics | $12.35 | 474.9% | Brian Cheng39% | → $71 | Initiates | → Overweight | Get Alert |
| 06/15/2021 | ADCT | Buy Now | ADC Therapeutics | $3.07 | 1399.74% | Brian Cheng39% | → $46 | Initiates | → Overweight | Get Alert |
| 12/16/2016 | RGLS | Buy Now | Regulus Therapeutics | $8.20 | 34.15% | Brian Cheng39% | → $11 | Initiates | → Overweight | Get Alert |
